(Q43248041)

17 November 2017

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis (English)

1 reference

17 November 2017

5

1 reference

17 November 2017

15

1 reference

17 November 2017

4

Yoon-Keun Kim

1 reference

17 November 2017

3

Joon-Woo Bahn

1 reference

17 November 2017

6

Eun-Soon Shin

1 reference

17 November 2017

13

Hae-Sim Park

1 reference

17 November 2017

Sang-Heon Kim

1

1 reference

17 November 2017

Sang-Hoon Kim

2

1 reference

17 November 2017

Youn-Seup Kim

7

1 reference

17 November 2017

Jae-Seuk Park

8

1 reference

17 November 2017

Bo-Hyung Kim

9

1 reference

17 November 2017

In-Jin Jang

10

1 reference

17 November 2017

Junghan Song

11

1 reference

17 November 2017

Seung-Hyun Kim

12

1 reference

17 November 2017

Kyung-Up Min

14

1 reference

17 November 2017

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

10

1 reference

17 November 2017

1767-1779

1 reference

17 November 2017

11

1 reference

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

17 November 2017

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Antituberculosis drugs and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Update on consensus arylamine N-acetyltransferase gene nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Haplotype analysis in population genetics and association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Role of metabolism in drug-induced idiosyncratic hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.100

21 January 2018

Identifiers

DOI

10.2217/PGS.09.100

1 reference

17 November 2017

1 reference